Literature DB >> 22814976

Cryptogenic stroke in low-risk patients, consider a cardiac shunt at your peril.

Laura Parry1, Saad Aldeen Saeed, Rumi Jaumdally.   

Abstract

Patent foramen ovale (PFO) as a cause of cryptogenic stroke from paradoxical embolisation remains a controversial issue. The optimal care between medical and surgical management of these patients for the attending clinician remains a conundrum. We report a case of cryptogenic stroke in a woman aged 59, with a PFO, concomitant venous thrombosis and cryptogenic stroke. The case highlights the difficulty in diagnosing and managing such patients, particularly as recent evidence challenges the clinical practice of percutaneous closure and pathophysiological rationale.

Entities:  

Mesh:

Year:  2012        PMID: 22814976      PMCID: PMC4543272          DOI: 10.1136/bcr-03-2012-6081

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Indication and techniques of transcatheter closure of patent foramen ovale.

Authors:  Rainer Schräder
Journal:  J Interv Cardiol       Date:  2003-12       Impact factor: 2.279

Review 2.  Is patent foramen ovale a modifiable risk factor for stroke recurrence?

Authors:  David M Kent; David E Thaler
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

3.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.

Authors:  Irene Meissner; Bijoy K Khandheria; John A Heit; George W Petty; Sheldon G Sheps; Gary L Schwartz; Jack P Whisnant; David O Wiebers; Jody L Covalt; Tanya M Petterson; Teresa J H Christianson; Yoram Agmon
Journal:  J Am Coll Cardiol       Date:  2005-12-06       Impact factor: 24.094

Review 4.  Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence.

Authors:  Georgios D Kitsios; Issa J Dahabreh; Abd Moain Abu Dabrh; David E Thaler; David M Kent
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

5.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

Authors:  P T Hagen; D G Scholz; W D Edwards
Journal:  Mayo Clin Proc       Date:  1984-01       Impact factor: 7.616

6.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Authors:  Anthony J Furlan; Mark Reisman; Joseph Massaro; Laura Mauri; Harold Adams; Gregory W Albers; Robert Felberg; Howard Herrmann; Saibal Kar; Michael Landzberg; Albert Raizner; Lawrence Wechsler
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

Review 7.  Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis.

Authors:  M A Almekhlafi; S B Wilton; D M Rabi; W A Ghali; D L Lorenzetti; M D Hill
Journal:  Neurology       Date:  2009-05-13       Impact factor: 9.910

8.  Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.

Authors:  M Braun; V Gliech; A Boscheri; S Schoen; G Gahn; H Reichmann; M Haass; R Schraeder; R H Strasser
Journal:  Eur Heart J       Date:  2004-03       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.